BCG vaccination appears promising as a treatment for people with existing type 1 diabetes, Phase I trial results show

Researchers in Massachusetts have announced the completion of the Phase I BCG clinical trial in type 1 diabetes. Plans for the Phase II clinical study, which will continue the investigation of bacillus Calmette-Guerin vaccination as a treatment type 1 diabetes, are actively underway.

Read the whole article on Science Daily

More from Science Daily